<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04279184</url>
  </required_header>
  <id_info>
    <org_study_id>SJ-493</org_study_id>
    <nct_id>NCT04279184</nct_id>
  </id_info>
  <brief_title>Urinary Incontinence and Endocrine Factors. A Part of Lolland-Falster Health Study (LOFUS).</brief_title>
  <acronym>EFUI</acronym>
  <official_title>Urinary Incontinence and Endocrine Factors.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nykøbing Falster County Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Region Zealand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nykøbing Falster County Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous studies have shown an increase in the prevalence of urgency and urgency incontinence&#xD;
      in women with diabetes. Regarding the condition urinary stress incontinence, the literature&#xD;
      is diverted.&#xD;
&#xD;
      The purpose of the PhD project is investigate the prevalence of urinary incontinence and the&#xD;
      association to diabetes and thyroid disease in a mainly rual population in Lolland and&#xD;
      Falster. Further to investigate if there is any difference in the bladder function in&#xD;
      incontinent women with and without diabetes.&#xD;
&#xD;
      Psychometric validation of the questionnaire used to assess urinary incontinence was also&#xD;
      performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Actual">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of urinary incontinence</measure>
    <time_frame>4 years</time_frame>
    <description>Assess by self-administered questionnaire and register data. Cross-sectional, measure once. The questionnaire International Consultation on Incontinence Questionnaire - Urinary Incontinence Short form (ICIQ-UI SF) was used to assess urinary incontinence (UI). It consist of six questions, and the score of three of the questions (assessing frequency of UI, volume of leak and bother) sums up to a total score. It ranges between 0-21 where 0 is no incontinence and a higher score indicates more severe symptoms of UI. The inclusion of participants are over a period of four years.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychometric validation of ICIQ-UI SF (questionnaire used to assess urinary incontinence)</measure>
    <time_frame>2 years</time_frame>
    <description>We investigated the predictive validity, internal consistency, patient-interview agreement, construct validity, test-retest reliability, and sensitivity to change for the ICIQ-UI SF.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between urinary incontinence and diabetes</measure>
    <time_frame>4 years</time_frame>
    <description>Assess by self-administered questionnaire and register data. Cross-sectional, measure once. The inclusion of participants are over a period of four years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants demographics</measure>
    <time_frame>4 years</time_frame>
    <description>Assess by self-administered questionnaire and register data. Cross-sectional, measure once. The inclusion of participants are over a period of four years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective characterization of urinary incontinence in women with and without diabetes</measure>
    <time_frame>2 years</time_frame>
    <description>Assess by urodynamics studies. Description of type of urinary incontinence, first sensation (ml), normal desire (ml), urgency (ml), max capacity (ml) and PVR (ml). Measured once for each participants. Data collected over a period of two years.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Urinary Incontinence</condition>
  <condition>Diabetes</condition>
  <condition>Thyroid Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The population of Lolland and Guldborgsund municipalities in Denmark.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  woman&#xD;
&#xD;
          -  18 years or above&#xD;
&#xD;
          -  participating i The Lolland-Falster Health Study (NCT02482896)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  male&#xD;
&#xD;
          -  below 18 years&#xD;
&#xD;
          -  non-participating i The Lolland-Falster Health Study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Helga Gimbel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ea Løwenstein</last_name>
    <phone>+4521930326</phone>
    <email>eapl@regionsjaelland.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Randi Jepsen</name>
      <address>
        <city>Nykøbing Falster</city>
        <state>Danmark</state>
        <zip>4800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randi Jepsen</last_name>
      <phone>+4556516860</phone>
      <email>rjep@regionsjaelland.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2020</study_first_posted>
  <last_update_submitted>November 26, 2020</last_update_submitted>
  <last_update_submitted_qc>November 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

